Table 2: Pathogen distribution and sensitive antibiotics after ureter anastomosis.
| Pathogen | Proportion | Sensitive antibiotics |
| Gram-negative | 158/198 | - |
| Normal E. coli | 48/198 | First, second-generation cephalosporins |
| ESBL E. coli | 41/198 | Third, fourth-generation cephalosporins, carbopenems |
| Acinetobacter baumannii | 14/198 | Third, fourth-generation cephalosporins, carbopenems |
| klebsiella pneumoniae | 13/198 | Third, fourth-generation cephalosporins, carbopenems |
| ESBL klebsiella pneumoniae | 6/198 | Carbopenems |
| Pseudomonas aeruginosa | 24/198 | Third, fourth-generation cephalosporins, carbopenems |
| MDR Pseudomonas aeruginosa | 3/198 | Carbopenems |
| Enterobacter cloacae | 4/198 | Third, fourth-generation cephalosporins, carbopenems |
| Others | 5/198 | - |
| Gram-positive | 33/198 | - |
| MRSA | 5/198 | Vancomycin, linezolid |
| Staphylococcus aureus | 4/198 | First-generation cephalosporins |
| Staphylococcus epidermidis | 3/198 | Third, fourth-generation cephalosporins, Vancomycin, linezolid |
| Enterococcus faecium | 7/198 | Vancomycin, linezolid |
| Enterococcus faecalis | 10/198 | Third, fourth-generation cephalosporins, vancomycin, linezolid |
| Others | 4/198 | - |
| Fungi | 7/198 | Anti-fungals |